Telehealth practice recommendations for diabetic retinopathy, second edition

Telemedicine and e-Health

Volumn 17, Issue 10, 2011, Pages 814-837

  Li, Helen K ^a,b,c   Horton, Mark ^d   Bursell, Sven Erik ^e   Cavallerano, Jerry ^f   Zimmer Galler, Ingrid ^g   Tennant, Mathew ^h   Abramoff, Michael ⁱ   Chaum, Edward ^j   Debuc, Debra Cabrera ^k   Leonard Martin, Tom ^l   Winchester, Marc ^m  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d PHOENIX INDIAN MEDICAL CENTER   (United States)

^e UNIVERSITY OF HAWAII   (United States)

^f JOSLIN DIABETES CENTER   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^j UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^k UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^l Insight Diagnostics Inc   (United States)

^m Digital Healthcare Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL SETTINGS; DIABETIC PATIENT; DIABETIC RETINOPATHY; EXPERT TEAMS; KEY FACTORS; TELEHEALTH; VISION LOSS;

EYE PROTECTION; MEDICAL COMPUTING;

TELEMEDICINE;

DIABETIC RETINOPATHY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; INSTRUMENTATION; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PRACTICE GUIDELINE; PROGRAM DEVELOPMENT; REVIEW; TELEMEDICINE; UNITED STATES;

DIABETIC RETINOPATHY; GUIDELINE ADHERENCE; HEALTH POLICY; HUMANS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; TELEMEDICINE; UNITED STATES;

EID: 82455179553     PISSN: 15305627     EISSN: 15563669     Source Type: Journal    
DOI: 10.1089/tmj.2011.0075     Document Type: Article

References (161)

1. Telemedicine Defined. Available at www.americantelemed.org/i4a/pages/ index.cfm?pageid = 3333 (last accessed September 23, 2011).
2. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-932.
3. Diabetes Public Health Resource. Available at www.cdc.gov/diabetes/pubs/ factsheets/atwork.htm (last accessed September 23, 2011).
4. Harris MI. Diabetes melitus: Summary. In: Harris MI, Cowie CC, Stern MP, et al., eds. Diabetes in America. Bethesda, MD: National Institutes of Health, 1995:1-13
5. NIH Publication no. 95-1468. Available at http://diabetes.niddk.nih.gov/ dm/pubs/america/pdf/chapter1.pdf (last accessed September 23, 2011).
6. Centers for Disease Control and Prevention. National diabetes fact sheet: General information and national estimates on diabetes in the United States. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.
7. Kempen JH, O'Colmain BJ, Leske MC, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004;122:552-563. (Pubitemid 38456292)
8. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053. (Pubitemid 38579764)
9. Saaddine JB, Honeycutt AA, Narayan KM, Zhang X, Klein R, Boyle JP. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol 2008;126:1740-1747.
10. IDF Diabetes Atlas. Global Burden: Prevalence and Projections, 2010 and 2030. 2010. Available at www.diabetesatlas.org/content/diabetes-andimpaired- glucose-tolerance (last accessed September 23, 2011).
11. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-526. (Pubitemid 14127838)
12. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102: 527-532. (Pubitemid 14127839)
13. [WHO] World Health Organization. Diabetes estimates and projections. WHO, 2008. Available at www.who.int/mediacentre/factsheets/fs312/en/index.html (last accessed June 2, 2009).
14. Klein R. The epidemiology of diabetic retinopathy: Findings from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Int Ophthalmol Clin 1987;27:230-238.
15. Klein R, Klein BE, Moss SE. The Wisconsin epidemiological study of diabetic retinopathy: A review. Diabetes Metab Rev 1989;5:559-570. (Pubitemid 19272666)
16. Kohner EM, Aldington SJ, Stratton IM, et al. United Kingdom Prospective Diabetes Study, 30: Diabetic retinopathy at diagnosis of non-insulindependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998;116:297-303.
17. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care 1998;21:143-156. (Pubitemid 28030402)
18. Ferris FL, 3rd, Patz A. Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol 1984;28(Suppl):452-461. (Pubitemid 14076504)
19. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995;102:7-16.
20. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 1984;91:1464-1474. (Pubitemid 15197017)
21. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 1981;88:583-600.
22. Photocoagulation treatment of proliferative diabetic retinopathy: Relationship of adverse treatment effects to retinopathy severity. Diabetic retinopathy study report no. 5. Dev Ophthalmol 1981;2:248-261.
23. Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group. Arch Ophthalmol 1979;97:654-655.
24. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. JAMA 1992;268:1292-1300.
25. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98:823-833.
26. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98:766-785.
27. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985;103:1796-1806.
28. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 1995;113:1144-1155.
29. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000;342:381-389.
30. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999;22: 99-111.
31. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998;116:874-886.
32. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. JAMA 1996;276:1409-1415.
33. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes 1996;45:1289-1298.
34. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968-983.
35. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Ophthalmology 1995;102:647-661.
36. Babaya N. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-2569.
37. White NH, Sun W, Cleary PA, et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol 2008;126:1707-1715.
38. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.
39. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-713.
40. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-1589.
41. Diabetic Retinopathy Clinical Research Network. DRCRnet manual of operations. Version 3.0. Tampa, FL: Jaeb Center for Health Research Foundation, April 8, 2005.
42. Diabetic Retinopathy Clinical Research Network (DRCRnet) public web site. Available at http://drcrnet.jaeb.org/ViewPage.aspx?PageName = Home-Page (last accessed September 23, 2011).
43. National Committee for Quality Assurance's 2009 State of Health Care Quality Report. Available at www.ncqa.org/tabid/836/Default.aspx (last accessed September 23, 2011).
44. Witkin SR, Klein R. Ophthalmologic care for persons with diabetes. JAMA 1984;251:2534-2537. (Pubitemid 14149006)
45. Sprafka JM, Fritsche TL, Baker R, Kurth D, Whipple D. Prevalence of undiagnosed eye disease in high-risk diabetic individuals. Arch Intern Med 1990;150:857-861. (Pubitemid 20122063)
46. Javitt JC, Aiello LP, Chiang Y, Ferris FL, III, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care 1994;17:909-917. (Pubitemid 24235519)
47. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996;124:164-169. (Pubitemid 26011617)
48. World Health Organization. Telehealth and telemedicine will henceforth be part of the strategy for Health-for-All. Press release, World Health Organization, December 23, 1997. Available at http://www.who.int/inf-pr-1997/en/ pr97-98.html (last accessed February 27, 2006).
49. Standards of medical care in diabetes-2009. Diabetes Care 2009;32(Suppl 1):S13-S61.
50. Fransen SR, Leonard-Martin TC, Feuer WJ, Hildebrand PL. Clinical evaluation of patients with diabetic retinopathy: Accuracy of the Inoveon diabetic retinopathy-3DT system. Ophthalmology 2002;109:595-601. (Pubitemid 34187645)
51. Bursell SE, Cavallerano JD, Cavallerano AA, et al. Stereo nonmydriatic digitalvideo color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology 2001;108:572-585. (Pubitemid 32179901)
52. Rudnisky CJ, Hinz BJ, Tennant MT, de Leon AR, Greve MD. High-resolution stereoscopic digital fundus photography versus contact lens biomicroscopy for the detection of clinically significant macular edema. Ophthalmology 2002;109:267-274. (Pubitemid 34106029)
53. Cavallerano AA, Cavallerano JD, Katalinic P, Tolson AM, Aiello LP, Aiello LM. Use of Joslin Vision Network digital-video nonmydriatic retinal imaging to assess diabetic retinopathy in a clinical program. Retina 2003;23:215-223. (Pubitemid 36548815)
54. Wilkinson CP, Ferris FL, 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-1682. (Pubitemid 37025422)
55. Scanlon PH, Foy C, Malhotra R, Aldington SJ. The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening. Diabetes Care 2005;28:2448-2453. (Pubitemid 41384292)
56. Murgatroyd H, Ellingford A, Cox A, et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol 2004;88:920-924. (Pubitemid 38869555)
57. Pandit RJ, Taylor R. Mydriasis and glaucoma: Exploding the myth. A systematic review. Diabet Med 2000;17:693-699.
58. Whited JD. Accuracy and reliability of teleophthalmology for diagnosing diabetic retinopathy and macular edema: A review of the literature. Diabetes Technol Ther 2006;8:102-111.
59. Bresnick GH, Mukamel DB, Dickinson JC, Cole DR. A screening approach to the surveillance of patients with diabetes for the presence of visionthreatening retinopathy. Ophthalmology 2000;107:19-24. (Pubitemid 30210176)
60. Blum J. Internet medicine and the evolving legal status of the physicianpatient relationship. J Leg Med 2003;4:413-455. (Pubitemid 38032988)
61. Kasztelowicz P. Security of medical data transfer and storage in Internet cryptography, antiviral security and electronic signature problems, which must be solved in nearest future in practical contest. Pol J Pathol 2003;3:209-214. (Pubitemid 38009573)
62. Brebner E, Bebner J, Ruddick-Bracken H, Wootton R, Ferguson J. The importance of setting and evaluating standards of telemedicine training. J Telemed Telecare 2003;9:7-9.
63. Lee P. Telemedicine: Opportunities and challenges for the remote care of diabetic retinopathy. Arch Ophthalmol 1999;117:1639-1640. (Pubitemid 30003299)
64. Zeimer R, Zou S, Meeder T, Quinn K, Vitale S. A fundus camera dedicated to the screening of diabetic retinopathy in the primary-care physician's office. Invest Ophthalmol 2002;43:1581-1587. (Pubitemid 34462661)
65. Digital Imaging and Communications in Medicine (DICOM) Supplement 91: Ophthalmic photography image SOP classes. Available at ftp://medical.nema.org/ medical/dicom/final/sup91-ft2.pdf (last accessed December 8, 2009).
66. DICOMTM Digital IMaging and Communications in Medicine. Available at http://medical.nema.org/(last accessed September 23, 2011).
67. Health Level Seven International (HL7). Available at www.hl7.org (last accessed September 23, 2011).
68. IHE Eye Care (EYECARE) Technical Framework Volume 1 (EYECARE TF-1) Integration Profiles. Revision 3.7-Final Text February 15, 2010. Available at www.ihe.net/Technical-Framework/upload/ihe-eyecare-tf-rev3-7-vol1-Final-Text- 2010-02-15.pdf (last accessed September 23, 2011).
69. IHE Eye Care (EYECARE) Technical Framework Volume 2 (EYECARE TF-1) Transactions. Revision 3.7-Final Text February 15, 2010. Available at www.ihe.net/Technical-Framework/upload/ihe-eyecare-tf-rev3-7-vol2-Final-Text- 2010-02-15.pdf (last accessed September 23, 2011).
70. SNOMED Terminology Solutions. Available at http://www.nlm.nih.gov/ research/umls/Snomed/snomed-main.html (last accessed September 23, 2011).
71. HITSP. Available at www.hitsp.org (last accessed September 23, 2011).
72. Digital Imaging and Communications in Medicine (DICOM) Supplement 61: JPEG 2000 Transfer Syntaxes. Available at ftp://medical.nema.org/medical/dicom/ final/sup61-ft.pdf (last accessed December 8, 2009).
73. Kuzmak PM, Dayhoff RE. Minimizing Digital Imaging and Communications in Medicine (DICOM) Modality Worklist patient/study selection errors. J Digit Imaging 2001;14:153-157. (Pubitemid 32804814)
74. Csipo D, Dayhoff RE, Kuzmak PM. Integrating Digital Imaging and Communications in Medicine (DICOM)-structured reporting into the hospital environment. J Digit Imaging 2001;14:12-16. (Pubitemid 32804813)
75. American Academy of Ophthalmology Preferred Practice Pattern. Diabetic Retinopathy. September 2008. Available at http://one.aao.org/CE/ PracticeGuidelines/PPP-Content.aspx?cid = dOc853d3-219f-4876-a524-326ab3cecd9a (last accessed September 23, 2011).
76. American Academy of Ophthalmology Summary Benmarks for Preferred Practice Pattern Guidlines Retinopathy. November 2008. Available at http://one.aao.org/ CE/PracticeGuidelines/default.aspx? = 783ead7d-3e06-433b-8f17-2971eb3816f8 (last accessed September 23, 2011).
77. Optometric Clinical Practice Guideline: Care of the Patient with Diabetes Mellitus. Available at www.aoa.org/documents/CPG-3.pdf (last accessed September 23, 2011).
78. Silverman R. Current legal and ethical concerns in telemedicine and e-medicine. J Telemed Telecare 2003;9:7-9.
79. Bilimoria N. Telemedicine: Laws still need a dose of efficiency. J Med Pract Manage 2003;6:289-294.
80. U.S. Department of Health and Human Services. Health information privacy: Summary of HIPAA Privacy Rule. Available at www.hhs.gov/ocr/privacy/hipaa/ understanding/summary/index.html (last accessed September 23, 2011).
81. An Introductory Resource Guide for Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule. National Institute of Standards and Technology, NIST Special Publication 800-66 Revision 1. Available at http://csrc.nist.gov/publications/nistpubs/800-66-Rev1/SP-800-66-Revision1. pdf (last accessed September 23, 2011).
82. Eliasson A, Poropatich R. Performance improvement in telemedicine: The essential elements. Mil Med 1998;8:530-535. (Pubitemid 28381340)
83. Comprehensive accreditation manual for hospitals: The official handbook. MS.4.120. MS.4.130.: The Joint Commission on the Accreditation of Healthcare Organizations. Oakwood Terrace, IL: Joint Commission Resources, 2008.
84. AMA, Physician Licensure: An update of trends. Available at www.ama-assn.org/ama/pub/about-ama/our-people/member-groups-sections/ young-physicianssection/advocacy-resources/physician-licensure-an-update-trends. page (last accessed September 23, 2011).
85. Center for Telemedicine Law. OAT Telemedicine Licensure Report, June 2003. Available at http://www.hrsa.gov/ruralhealth/about/telehealth/licenserpt03 .pdf (last accessed September 23, 2011).
86. Rigelhaupt JL. Annotation, what constitutes physician-patient relationship for malpractice purposes, 17 A.L.R. 4th 132, 1982.
87. E-Health and Antitrust. Telemedicine and E-Health Law, Rel 7. Ch7, 1.04[3a]. New York: Law Journal Press, 2008.
88. AMA. Policy Statement H-480.968, Telemedicine. Available at http://www.tgender.net/taw/ama-resolutions.pdf (last accessed September 23, 2011).
89. VA. VHA Informed consent for clinical treatments and procedures: VA. VHA Handbook 1004.1 Transmittal Sheet. 2003. Available at http://taskforcefido.com/ files/VhaInformedConsent.pdf (last accessed September 23, 2011).
90. Stanberry B. Legal ethical and risk issues in telemedicine. Comput Methods Programs Biomed 2001;64:225-233. (Pubitemid 32162514)
91. Iserson K. Telemedicine: A proposal for an ethical code. Camb Q Healthc Ethics 2000;9:404-406.
92. Mossman K. Medical testing: Issues and ethics. Forum Appl Res Public Policy 1997;3:90-101. (Pubitemid 127652425)
93. Borkowski W, Mielniczuk H. Telemedical management system of structured clinical documentation-application for quality assurance and multicenter clinical trials. Pol J Pathol 2003;3:193-195. (Pubitemid 38009570)
94. McCrossin R. Managing risk in telemedicine. J Telemed Telecare 2003;9:6-9.
95. Spencer T, Olson JA, McHardy KC, Sharp PF, Forrester JV. An image-processing strategy for the segmentation and quantification of microaneurysms in fluorescein angiograms of the ocular fundus. Comput Biomed Res 1996;29:284-302. (Pubitemid 26301912)
96. Fleming AD, Goatman KA, Philip S, Olson JA, Sharp PF. Automatic detection of retinal anatomy to assist diabetic retinopathy screening. Phys Med Biol 2007;52:331-345. (Pubitemid 46646455)
97. Usher D, Dumskyj M, Himaga M, Williamson TH, Nussey S, Boyce J. Automated detection of diabetic retinopathy in digital retinal images: A tool for diabetic retinopathy screening. Diabet Med 2004;21:84-90. (Pubitemid 38168035)
98. Staal J, Abramoff MD, Niemeijer M, Viergever MA, van Ginneken B. Ridgebased vessel segmentation in color images of the retina. IEEE Trans Med Imaging 2004;23:501-509.
99. Lowell J, Hunter A, Steel D, et al. Optic nerve head segmentation. IEEE Trans Med Imaging 2004;23:256-264.
100. Martinez-Perez ME, Hughes AD, Thom SA, Bharath AA, Parker KH. Segmentation of blood vessels from red-free and fluorescein retinal images. Med Image Anal 2007;11:47-61. (Pubitemid 46202206)
101. Solouma NH, Youssef AB, Badr YA, Kadah YM. A new real-time retinal tracking system for image-guided laser treatment. IEEE Trans Biomed Eng 2002;49:1059-1067. (Pubitemid 34925476)
102. Smith RT, Chan JK, Nagasaki T, et al. Automated detection of macular drusen using geometric background leveling and threshold selection. Arch Ophthalmol 2005;123:200-206. (Pubitemid 40189707)
103. Gregson PH, Shen Z, Scott RC, Kozousek V. Automated grading of venous beading. Comput Biomed Res 1995;28:291-304.
104. Hejlesen O, Ege B, Englmeier KH, Aldington S, McCanna L, Bek T. TOSCAImaging-developing Internet based image processing software for screening and diagnosis of diabetic retinopathy. Stud Health Technol Inform 2004;107:222-226.
105. Kozousek V, Shen Z, Gregson P, Scott RC. Automated detection and quantification of venous beading using Fourier analysis. Can J Ophthalmol 1992;27:288-294. (Pubitemid 23009378)
106. Asrani S, Zeimer R, Goldberg MF, Zou S. Application of rapid scanning retinal thickness analysis in retinal diseases. Ophthalmology 1997;104:1145-1151. (Pubitemid 27423858)
107. Sadda SR, Tan O, Walsh AC, Schuman JS, Varma R, Huang D. Automated detection of clinically significant macular edema by grid scanning optical coherence tomography. Ophthalmology 2006;113:1187, e1-e12.
108. Van Dijk HW, Kok PH, Garvin M, et al. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci 2009;50:3404-3409.
109. Cabrera Debuc D, Somfai GM. Early detection of retinal thickness changes in diabetes using optical coherence tomography. Med Sci Monit 2010;16:MT 15-21.
110. Larsen M, Godt J, Larsen N, et al. Automated detection of fundus photographic red lesions in diabetic retinopathy. Invest Ophthalmol Vis Sci 2003;44:761-766. (Pubitemid 36159727)
111. Englmeier KH, Schmid K, Hildebrand C, et al. Early detection of diabetes retinopathy by new algorithms for automatic recognition of vascular changes. Eur J Med Res 2004;9:473-478.
112. Larsen N, Godt J, Grunkin M, Lund-Andersen H, Larsen M. Automated detection of diabetic retinopathy in a fundus photographic screening population. Invest Ophthalmol Vis Sci 2003;44:767-771. (Pubitemid 36159728)
113. Fleming AD, Philip S, Goatman KA, Williams GJ, Olson JA, Sharp PF. Automated detection of exudates for diabetic retinopathy screening. Phys Med Biol 2007;52:7385-7396. (Pubitemid 350242846)
114. Junge J, Boon KL, Ottens DE. Automatic information processing in diabetic retinopathy. Ophthalmologica 1975;171:3-6.
115. Muller W, Spittel U, Gobel H. First results of the computer-aided classification of electroretinograms. Ophthalmologica 1986;192:228-233. (Pubitemid 16005817)
116. Guo W, Marshall G. ORDMKV: A computer program fitting proportional odds model for multi-state Markov process. Comput Methods Programs Biomed 1995;46:257-263.
117. Marshall G, Guo W, Jones RH. MARKOV: A computer program for multi-state Markov models with covariables. Comput Methods Programs Biomed 1995;47:147-156.
118. Zana F, Klein JC. A multimodal registration algorithm of eye fundus images using vessels detection and Hough transform. IEEE Trans Med Imaging 1999;18:419-428.
119. Zahlmann G, Kochner B, Ugi I, et al. Hybrid fuzzy image processing for situation assessment. IEEE Eng Med Biol Mag 2000;19:76-83. (Pubitemid 30056689)
120. Niemeijer M, van Ginneken B, Staal J, Suttorp-Schulten MS, Abramoff MD. Automatic detection of red lesions in digital color fundus photographs. IEEE Trans Med Imaging 2005;24:584-592. (Pubitemid 40680120)
121. Chanwimaluang T, Fan G, Fransen SR. Hybrid retinal image registration. IEEE Trans Inf Technol Biomed 2006;10:129-142. (Pubitemid 43092326)
122. Walter T, Klein JC, Massin P, Erginay A. A contribution of image processing to the diagnosis of diabetic retinopathy-detection of exudates in color fundus images of the human retina. IEEE Trans Med Imaging 2002;21:1236-1243.
123. Sanchez CI, Garcia M, Mayo A, Lopez MI, Hornero R. Retinal image analysis based on mixture models to detect hard exudates. Med Image Anal 2009;13:650-658.
124. Goldberg RE, Varma R, Spaeth GL, Magargal LE, Callen D. Quantification of progressive diabetic macular nonperfusion. Ophthalmic Surg 1989;20:42-45.
125. Abramoff MD, Niemeijer M, Suttorp-Schulten MS, Viergever MA, Russell SR, van Ginneken B. Evaluation of a system for automatic detection of diabetic retinopathy from color fundus photographs in a large population of patients with diabetes. Diabetes Care 2008;31:193-198. (Pubitemid 351213318)
126. Bouhaimed M, Gibbins R, Owens D. Automated detection of diabetic retinopathy: Results of a screening study. Diabetes Technol Ther 2008;10:142-148. (Pubitemid 351230283)
127. Sinthanayothin C, Boyce JF, Williamson TH, et al. Automated detection of diabetic retinopathy on digital fundus images. Diabet Med 2002;19:105-112. (Pubitemid 34225223)
128. Gonzalez Villalpando C, Gonzalez Villalpando ME, Martinez Diaz S, et al. A diabetic retinopathy screening program as a strategy for blindness prevention. Arch Med Res 1997;28:129-135.
129. Goatman KA, Cree MJ, Olson JA, Forrester JV, Sharp PF. Automated measurement of microaneurysm turnover. Invest Ophthalmol Vis Sci 2003;44:5335-5341. (Pubitemid 37475407)
130. Hipwell JH, Strachan F, Olson JA, McHardy KC, Sharp PF, Forrester JV. Automated detection of microaneurysms in digital red-free photographs: A diabetic retinopathy screening tool. Diabet Med 2000;17:588-594.
131. Cree MJ, Olson JA, McHardy KC, Sharp PF, Forrester JV. A fully automated comparative microaneurysm digital detection system. Eye (Lond) 1997;11:622-628. (Pubitemid 27499815)
132. Baudoin CE, Lay BJ, Klein JC. Automatic detection of microaneurysms in diabetic fluorescein angiography. Rev Epidemiol Sante Publique 1984;32:254-261. (Pubitemid 15196778)
133. Fleming AD, Philip S, Goatman KA, Olson JA, Sharp PF. Automated microaneurysm detection using local contrast normalization and local vessel detection. IEEE Trans Med Imaging 2006;25:1223-1232. (Pubitemid 44304281)
134. Spencer T, Phillips RP, Sharp PF, Forrester JV. Automated detection and quantification of microaneurysms in fluorescein angiograms. Graefes Arch Clin Exp Ophthalmol 1992;230:36-41.
135. Sleightholm MA, Arnold J, Aldington SJ, Kohner EM. Computer-aided digitisation of fundus photographs. Clin Phys Physiol Meas 1984;5:295-301. (Pubitemid 15157734)
136. Frame AJ, Undrill PE, Cree MJ, et al. A comparison of computer based classification methods applied to the detection of microaneurysms in ophthalmic fluorescein angiograms. Comput Biol Med 1998;28: 225-238. (Pubitemid 28435138)
137. Sivakumar R, Ravindran G, Muthayya M, Lakshminarayanan S, Velmurughendran CU. Diabetic retinopathy analysis. J Biomed Biotechnol 2005;2005:20-27. (Pubitemid 41022983)
138. Nayak J, Bhat PS, Acharya R, Lim CM, Kagathi M. Automated identification of diabetic retinopathy stages using digital fundus images. J Med Syst 2008;32:107-115.
139. Niemeijer M, van Ginneken B, Cree MJ, et al. Retinopathy online challenge: Automatic detection of microaneurysms in digital color fundus photographs. IEEE Trans Med Imaging 2010;29:185-195.
140. Abramoff MD, Reinhardt JM, Russell SR, et al. Automated early detection of diabetic retinopathy. Ophthalmology 2010;117:1147-1154.
141. Niemeijer M, van Ginneken B, Russell SR, Suttorp-Schulten MS, Abramoff MD. Automated detection and differentiation of drusen, exudates, and cotton-wool spots in digital color fundus photographs for diabetic retinopathy diagnosis. Invest Ophthalmol Vis Sci 2007;48:2260-2267. (Pubitemid 351261304)
142. Philip S, Fleming AD, Goatman KA, et al. The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme. Br J Ophthalmol 2007;91:1512-1517. (Pubitemid 350044057)
143. Abramoff MD, Niemeijer M, Russell SR. Automated detection of diabetic retinopathy: Barriers to translation into clinical practice. Expert Rev Med Devices 2010;7:287-296.
144. Hill NR, Matthews DR. Automated retinal image differencing (ARID). Abstracts of the 40th Annual Meeting of the European Association for the Study of Diabetes. Munich, Germany, 5-9 September 2004. Diabetologia 2004;47(Suppl 1):A1-A489.
145. Tobin KW, Abdelrahman M, Chaum E, Govindasamy V, Karnowski TP. A probabilistic framework for content-based diagnosis of retinal disease. Conf Proc IEEE Eng Med Biol Soc 2007;2007:6744-6747.
146. Chaum E, Karnowski TP, Govindasamy VP, Abdelrahman M, Tobin KW. Automated diagnosis of retinopathy by content-based image retrieval. Retina 2008;28:1463-1477.
147. LeBlanc K, Saffiotti A. Multirobot object localization: A fuzzy fusion approach. IEEE Trans Syst Man Cybern B Cybern 2009;39:1259-1276.
148. Nguyen TT, Wong TY. Retinal vascular changes and diabetic retinopathy. Curr Diab Rep 2009;9:277-283.
149. Bayu SasongkoM,Wang JJ, Donaghue KC, et al. Alterations in retinalmicrovascular geometry in young type 1 diabetes. Diabetes Care 2010;33:1331-1336.
150. Grauslund J, Green A, Kawasaki R, Hodgson L, Sjolie AK, Wong TY. Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes. Ophthalmology 2010;117:1400-1405.
151. Covered Entity Charts. Centers for Medicare and Medicaid Services. Available at www.cms.hhs.gov/HIPAAGenInfo/06-AreYouaCoveredEntity.asp (last accessed September 23, 2011).
152. Department of Health and Human Services. Medicare and Medicaid Programs: Proposed changes affecting hospital and critical access hospital (CAH) conditions of participation (CoPs): Credentialing and privileging of telemedicine physicians and practitioners. Federal Register, Vol. 75, No. 101. Available at http://edocket.access.gpo.gov/2010/pdf/2010-12647.pdf (last accessed September 23, 2011).
153. Blignault I, Kennedy C. Training for telemedicine. J Telemed Telecare 1999;5(Suppl) 1:S112-S114.
154. Comprehensive Accreditation Manual for Hospitals: The official handbook. EC6.10. MS.5.10: The Joint Commission on the Accreditation of Healthcare Organizations. Oakbrook Terrace, IL: Joint Commission Resources, 2004.
155. Scanlon PH. The English national screening programme for sight-threatening diabetic retinopathy. J Med Screen 2008;15:1-4. (Pubitemid 351629537)
156. Garvican L, Clowes J, Gillow T. Preservation of sight in diabetes: Developing a national risk reduction programme. Diabet Med 2000;17:627-634.
157. Arun CS, Young D, Batey D, et al. Establishing ongoing quality assurance in a retinal screening programme. Diabet Med 2006;23:629-634. (Pubitemid 43830063)
158. Schneider S, Aldington SJ, Kohner EM, et al. Quality assurance for diabetic retinopathy telescreening. Diabet Med 2005;22:794-802. (Pubitemid 40805904)
159. Centers for Medicare and Medicaid Services, Department of Health and Human Services. Medicare Program: Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011. Available at www.regulations.gov/#!documentDetail:D = CMS-2010-0205-1982 (last accessed February 6, 2011).
160. Ocular Special Interest Group, American Telemedicine Association. American Telemedicine Association comments on Diabetic Retinopathy Codes. Available at http://hub.americantelemed.org/AMERICANTELEMED/AMERICANTELEMED/ Resources/ViewDocument/Default.aspx?DocumentKey = 8fd1a5c2-9158-46a5-a0a4- e2843fd0cd96&MessageKey = dae865a4-f48c-4cee-87cec815c7e06bc1 (last accessed February 6, 2011).
161. Whited JD, Datta SK, Aiello LM, et al. Amodeled economic analysis of a digital teleophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy. Telemed J E Health 2005;11:641-651. (Pubitemid 43227819)